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Periodontal disease represents a group of oral inflammatory infections initiated by oral
pathogens which exist as a complex biofilms on the tooth surface and cause destruction
to tooth supporting tissues. The severity of this disease ranges from mild and reversible
inflammation of the gingiva (gingivitis) to chronic destruction of connective tissues, the
formation of periodontal pocket and ultimately result in loss of teeth. While human
subgingival plaque harbors more than 500 bacterial species, considerable research
has shown that Porphyromonas gingivalis, a Gram-negative anaerobic bacterium, is the
major etiologic agent which contributes to chronic periodontitis. This black-pigmented
bacterium produces a myriad of virulence factors that cause destruction to periodontal
tissues either directly or indirectly by modulating the host inflammatory response. Here,
this review provides an overview of P. gingivalis and how its virulence factors contribute
to the pathogenesis with other microbiome consortium in oral cavity.
Keywords: Porphyromonas gingivalis, oral pathogen, periodontal disease, gingivitis, virulence factors,
inflammatory response
INTRODUCTION
Periodontal diseases are complex, multifactorial, polymicrobial infections characterized by the
destruction of tooth-supporting tissues. The disease begins as acute inﬂammation of the gingival
tissue and untreated infections can progress to formation of teeth pockets, and eventually loss of
teeth. According to the World Health Organization, periodontal disease aﬀects 10–15% of adult
populations worldwide (Petersen and Ogawa, 2012).
Substantial data accumulated over the years has implicated the involvement of only a small
proportion of bacteria, which reside in the subgingival niche, in the initiation and progression of
periodontal disease. There is strong evidence that points to Porphyromonas gingivalis, a Gram-
negative anaerobes, as the keystone species in the development of chronic periodontitis.
The past decades of extensive research on P. gingivalis have produced various lines of evidences
on the contribution of this anaerobe to the progression of periondontal disease. These ﬁndings are
important in increasing our understanding on the virulence characteristics and cellular interaction
between P. gingivalis and the host, thereby elucidating potential therapeutic approaches to control
periodontal disease progression.
THE ORAL FLORA AND NORMAL PERIODONTIUM
The oral cavity possesses a number of features which make it a distinct habitat for a menagerie of
microorganisms. The surfaces in the oral cavity are continuously bathed in saliva most of the time
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at a narrow temperature range (34 to 36◦C) and a pH close
to neutrality (Marcotte and Lavoie, 1998). With such an ideal
environment, various classes of microﬂora are found to be
distributed in various ecological niches (Parahitiyawa et al.,
2010).
In general, the mouth harbors at least six billion bacteria
which are represented by more than 700 species (Theilade, 1990;
Aas et al., 2005), as well as other types of microorganisms,
including fungi, mycoplasma, protozoa, and possibly even viruses
(Pennisi, 2005). Generally, oral bacteria can be broadly classiﬁed
as Gram-positive and Gram-negative bacteria, and secondarily
as either anaerobic or facultatively anaerobic according to their
oxygen requirements. Some of the more frequently isolated
microorganisms in human oral cavity are listed in Table 1.
Despite the diverse community of oral microbiota, the oral
cavity is, nonetheless, characterized by a stable community
known as the climax community. Therefore, if imbalance in the
oral resident microbiota occurs, oral diseases such as caries and
periodontal diseases seem to appear, leading to multiplication
of potentially pathogenic microorganisms. Several studies have
illustrated that a change in microbial species in the gingival sulcus
from Gram-positive, facultative, fermentative microorganisms to
predominantly Gram-negative, anaerobic, chemoorganotrophic,
and proteolytic organisms has been highly associated with
destruction of periodontal tissue (Eloe-Fadrosh and Rasko, 2013).
PERIODONTAL DISEASES
Periodontal disease generally refers to inﬂammatory pathologic
state of the gingiva and the supporting structures of the
periodontium which include gingival, alveolar bone, periodontal
ligament, and cementum. They are commonly found in most
human populations and result in signiﬁcant morbidity, with
TABLE 1 | The predominant human oral microbiota.
Microbial group Microbial genus/species
Gram-positive
Aerobic or facultative Streptococcus (S. gordonii, S. mitis, S. auralis, S. salivarius)
Staphylococcus (S. aureus, S. epidermidis)
Enterococcus (E. faaecalis)
Lactobacillus (L. casei, L. fermentum)
Corynebacterium (C. matruchotii)
Actinomyces (A. naeslundii, A. israelli, A. viscosus)
Arachnia (A. propionica)
Rothia (R. dentocariosa)
Obligate anaerobes Bacillus (B. cereus)
Propionibacterium (P. acnes)
Peptostreptococcus (P. micros, P. anaerobius)
Gram-negative
Aerobic or facultative Campylobacter (C. rectus, C. concisus, C. gracilis)
Actinobacillus (A. actinomycetemcomitans)
Obligate anaerobes Fusobacterium (F. nucleatum)
Porphyromonas (P. gingivalis)
Prevotella (P. melaninogenica, P. oralis, P. intermedia)
exfoliation of the teeth in severe condition. In United States,
recent epidemiological data suggests that periondontal disease
aﬀects one-half of its population over 30 years of age and is the
major cause of tooth loss among adults (Bostanci and Belibasakis,
2012). According to the periodontal disease classiﬁcation system
proposed by the American Academy of Periodontology (AAP),
periodontal diseases are generally grouped into two major
categories, gingival diseases, and periodontitis, depending on
whether destruction of the periodontal attachment has occurred
(Wiebe and Putnins, 2000).
Gingival disease is deﬁned as inﬂammation of the gingival
tissues caused by accumulation of dental plaque and is
characterized clinically by redness, swelling, and bleeding of
the tissues. As the periodontal ligament and alveolar bone are
not involved in this event, the attachment of the teeth is not
aﬀected (Williams et al., 1992). Gingivitis can remain indeﬁnitely
for a long period and will not progress to periodontitis, unless
there are perturbations in local conditions or generalized host
susceptibility (Oﬀenbacher, 1996).
On the other hand, periodontitis refers to the irreversible
plaque-induced inﬂammation of the periodontal tissues leading
to destruction of the periodontal ligament and alveolar bone,
and migration of the epithelial ligament. Subsequently, this
causes formation of a periodontal pocket, the main clinical
feature of periodontitis (Williams et al., 1992). This pocket is
an ideal surface for bacterial colonization and the formation of
subgingival plaque.
Various studies have shown that periodontitis occurs more
often among patients with systemic diseases such as diabetes
mellitus, AIDS, leukemia, and Down’s syndrome (Komatsu,
2014; Mehta, 2015). A growing body of evidence suggests that
periodontitis may enhance the risk for several potentially deadly
conditions including cardiovascular diseases (e.g., heart attack,
coronary artery disease, and stroke) and diabetes (Saremi et al.,
2005; Friedewald et al., 2009). According to a report by AAP in
1996, it was found that people with some forms of gum disease
are almost twice as likely to suﬀer from coronary artery disease
compared to those with healthy gum.
For many years, numerous studies have been developed
to show the possible connection between periodontal disease
and cardiovascular disease. Recent studies, such as the study
of Nakano et al. (2006) attempted to show the direct
mechanisms that link periodontal diseases to cardiovascular
disease. A number of mechanisms have been proposed to
explain this association including a common factor that
predisposes certain individuals to hyper-inﬂammatory response
in cardiovascular disease (Beck et al., 1996). It is believed that oral
pathogens could enter the bloodstream and the inﬂammation
caused by periodontal disease increases plaque build up, which
subsequently contributes to dilation of the arteries (Bartold and
Narayanan, 2006). Figure 1 shows a simpliﬁed diagram of the
potential roles that periodontal inﬂammation might play in the
pathogenesis of cardiovascular diseases.
Streptococcus mutans, a major pathogenic agent of dental
caries, was detected in unusual high frequency in both heart
valve tissues and atheromatous plaque samples than any other
species (Nakano et al., 2006). In fact, together with P. gingivalis,
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FIGURE 1 | A simplified representation showing the association of
chronic periodontal inflammation and pathogenesis of cardiovascular
disease. Adapted from Bartold and Narayanan (2006).
S. mutans was previously found to accelerate atherogenic plaque
formation in a murine model and induce platelet aggregation,
which presumably leads to thrombus formation (Herzberg and
Meyer, 1996; Kuramitsu et al., 2001). The latest study by Oliveira
et al. (2015) showed that S. mutans, Prevotella intermedia, P.
gingivalis, and Treponema denticola were frequently detected in
cardiac valve samples using polymerase chain reaction (PCR)
method, corroborating previous ﬁndings. The high detection rate
of S. mutans in dental plaque samples may suggest that the
S. mutans found in the valve samples was originated from the oral
cavity. However, there is a concern of the possibility of detecting
DNA of dead bacteria due to the high sensitivity of real-time PCR.
On the other hand, the American Heart Association noted
that neither has periodontal disease been proven to cause
atherosclerotic vascular disease nor has the treatment of
periodontal disease been proven to prevent atherosclerotic
vascular disease (Lockhart et al., 2012). This was supported
by a report from Hayashi et al. (2015) in which there is an
absence of strong correlation between periodontal condition
and parameters of arteriosclerosis status in patients with
coronary artery disease. This study, however, also has some
limitations such as patients without coronary artery disease
were excluded and biomarker samples were not collected from
diﬀerent regions in oral cavity to reﬂect local imﬂammatory
conditions.
It was reported that periodontal disease and cardiovascular
disease share common risk factors such as smoking, diabetes
mellitus, aging, and obesity (Genco and Borgnakke, 2013).
Systemic inﬂammatory markers were also detected from both
diseases. Hence, evidence regarding a correlation between these
two diseases remains a challenging study. Other common
factors including lifestyle and personal hygiene also played
important roles in both diseases. With much conﬂicting
literature, there is a need to have additional long-term studies
to provide a strong causative link between periodontal and heart
diseases.
Besides cardiovascular disease, in vitro and animal model
studies suggest that P. gingivalis can breach immune tolerance
in susceptible individuals and exacerbate rheumatoid arthritis
through enzymatic modiﬁcation of host proteins (Maresz et al.,
2013). Apart from that, periodontal disease has also been found
to be a risk factor for pre-term low birth weight babies (Ali
and Abidin, 2012). The inﬂammatory mediators that occur in
periodontal disease have critical roles in the initiation of labor
and there are plausible mechanisms that could link the two
conditions (Williams et al., 2000). Based on epidemiological
and microbiological immunological studies, the postulated
mechanisms include translocation of periodontal pathogens to
the fetoplacental unit and action of a periodontal reservoir
of virulence factors as inﬂammatory mediators. However, the
relationship between adverse pregnancy outcomes and maternal
antibody response to P. gingivalis awaits further investigation
(Madianos et al., 2013).
BACTERIAL ETIOLOGY IN
PERIODONTAL DISEASES
Major advances have been made in these few decades
in understanding the pathogenesis and natural history of
periodontal diseases. Nevertheless, studies conducted in the
1930s to 1970s were unable to identify speciﬁc bacteria
as etiological agents of periodontal diseases. As such, the
“non-speciﬁc theory” was suggested, which hypothesizes that
periodontal disease is due to a consortium of microorganisms
rather than the importance of any bacterial species as the sole
causative agents (Theilade, 1986). However, in the late 1970s and
after, more speciﬁc microorganisms were isolated as etiological
agents of periodontitis (Tanner et al., 1979; Slots et al., 1986;
Moore and Moore, 1994).
It is now widely accepted that a myriad of bacteria and not
a single microorganism, are involved in periodontal diseases. In
fact, the onset of periodontal tissue inﬂammation is triggered
by the colonization of the subgingival region by periodontal
bacteria. On the tooth surfaces, for example, early or primary
colonizers are mainly streptococci and actinomyces. Over time,
the proportions of these Gram-positive facultatively anaerobic
bacteria decrease and eventually Gram-negative anaerobes
become more established, especially at the interface of the teeth
and gums (Jenkinson and Lamont, 2006).
Nonetheless, complex interactions between bacterial ﬂora
and the host defense mechanisms signiﬁcantly inﬂuence the
balance between bacterial aggression and host protection and
thus determines whether periodontal breakdown occurs
(Hajishengallis et al., 2012). In light of these criteria, a
number of experimental evidences have demonstrated that
the primary etiological agents of periodontal diseases are
generally Gram-negative rods which include Actinobacillus
actinomycetemcomitans, Tannerella forsythia (previously
designated Bacteroides forsythus), Prevotella, Fusobacterium, and
P. gingivalis. Not one of these microbial species is capable of
causing the destructive events involved in the periodontal disease
progression but the etiology requires a concerted interaction
of these members to establish their niches in the oral cavity
(Marcotte and Lavoie, 1998; Maiden et al., 2003; Paster et al.,
2006).
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PORPHYROMONAS GINGIVALIS AND
ITS PREVALENCE
Among major periodontal pathogens, P. gingivalis appears to
be one of the prime etiological agents in the pathogenesis and
progression of the inﬂammatory events of periodontal disease
(Hajishengallis et al., 2012). This periodontopathic bacterium
was found in 85.75% of subgingival plaque samples from
patients with chronic periodontitis (Datta et al., 2008). This non-
motile, asaccharolytic, Gram-negative bacterium is an obligately
anaerobic rod which forms black-pigmented colonies on blood
agar plates (Figure 2). It has an absolute requirement for iron
in its growth. It was formerly named Bacteroides gingivalis prior
to its reclassiﬁcation as a new genus, Porphyromonas (Nisengard
and Newman, 1994). The name Porphyromonas comes from the
Greek adjective porphyreos meaning purple and the Greek noun
monas meaning unit. Hence, the word Porphyromonas means
porphyrin cell as the colonies on blood agar plates turn black
after 6 to 10 days due to heme accumulation (Shah and Collins,
1988).
The major habitat of P. gingivalis is the subgingival sulcus
of the human oral cavity. It relies on the fermentation of
amino acids for energy production, a property required for its
survival in deep periodontal pocket, where sugar availability is
low (Bostanci and Belibasakis, 2012). Being an obligate anaerobe,
P. gingivalis serves as the secondary colonizer of dental plaque,
often adhering to primary colonizers such as Streptococcus
gordonii and P. intermedia. A study by Bodet et al. (2006)
demonstrated that this asaccharolytic bacterium is associated
with T. denticola and T. forsythia to form the red bacterial
complex which is highly recognized in advanced periodontal
lesions. Additional evidence for the presence of P. gingivalis
has also came from immunological studies (Moore et al., 1991;
Schmidt et al., 2014). Virtually, all investigators agree that serum
FIGURE 2 | Black-pigmented colonies of periodontopathogen
P. gingivalis on horse blood agar. The pigment is thought to be related to
accumulation of hemin (oxidized form of heme) on the cell surface when
grown on blood agar.
antibody levels to P. gingivalis are higher in patients diagnosed
with adult periodontitis (Mahanonda et al., 1991; Casarin et al.,
2010).
In the past few decades, P. gingivalis strains have been
classiﬁed into invasive and non-invasive strains based on their
ability to form abscesses in a mouse model. It has been
demonstrated that the invasive strain of P. gingivalis possesses
more pathogenic activities than the non-invasive strain both
in vitro and in vivo (Dorn et al., 2000; Baek et al., 2015).
The presence of P. gingivalis acting either alone or as a mixed
infection with other oral pathogens and possibly the deﬁciency
of certain immunological factors in the host appears to be
essential for the etiology of advanced periodontitis (Haﬀajee and
Socransky, 1994). The number of P. gingivalis has been shown
to increase substantially in sites with periodontitis and lower
or non-detectable in sites with subgingival health or plaque-
associated gingivitis (Schmidt et al., 2014). It usually resides in
higher proportion in deep than in shallow periodontal pockets
(Ali et al., 1996). About 40–100% of adult periodontitis patients
have been infected with these opportunistic bacteria.
With high frequency of P. gingivalis in adult periodontitis
lesions, it is strongly hypothesized that P. gingivalis interact with
other members of the host microbiota by synthesizing various
pathogenic factors, leading to the progression of the disease.
However, how P. gingivalis communicates with selective host
cells to produce destructive biological molecules and triggers the
conversion of a healthy oral tissue to a diseased state is yet to be
known (Holt et al., 1999).
VIRULENCE FACTORS OF P. gingivalis
The induction and progression of periodontal tissue destruction
are complex processes involving plaque accumulation, release
of bacterial substances, and host inﬂammatory response.
P. gingivalis is known to produce a repertoire of virulence
factors that could penetrate the gingivae and cause tissue
destruction directly or indirectly, by induction of inﬂammation
(Hajishengallis et al., 2012). Virulence factors may be deﬁned
as the constituents or metabolites of an organism which are
essential in various stages of the life cycle and cause damage
to the host. The capacity of an organism colonize and evade
anti-bacterial host defense mechanisms, as well as the ability
to produce substances that could initiate tissue destruction, are
integral features of a successful pathogen. Some of the virulence
factors are given in Table 2.
In order to survive and multiply in a host, the invading
pathogen needs to overcome the host external protective
barriers before it could ﬁnd a suitable ecological niche for
colonization. Colonization of the host tissues could only happen
in the presence of virulence factors such as ﬁmbriae, capsules,
lipopolysaccharide (LPS), lipoteichoic acids, haemagglutinins,
gingipains, outer membrane proteins, and outer membrane
vesicles (Holt et al., 1999; Hajishengallis and Lamont, 2014). The
expression of virulence factors is often regulated in response to
changes in the external environment of the periodontopathogen.
If active in a susceptible host, these virulence factors can result
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TABLE 2 | The virulence factors and host effectors produced by
P. gingivalis.
Virulence factors Effect on host evasion
Enzymes (hyaluronidase, chondroitin
sulfatase), capsule
Decrease phagocytosis for invasion,
chemotaxis inhibitors
Lipopolysaccharide Bone resorption, Immunoglobulin
proteases
Fimbriae, exopolysaccharide, outer
membrane proteins
Adhesion or attachment to host outer
membrane
Collagenase, trypsin-like protease,
gelatinase
Degradation of plasma protease
inhibitors, destruction of periodontal
tissue
Aminopeptidase Degradation of iron transport protein
in a rapid and signiﬁcant destruction of periodontal tissues, bone
resorption, induction of host responses by cytokine production,
as well as inhibition of host protective mechanisms. However, the
expression of these virulence determinants and their mechanism
during various stages of periodontal disease have not been
extensively investigated. To fully understand the speciﬁc function
of each factor and its mechanism in pathogenesis requires
inactivation of the factors coupled with biochemical evaluation
and in vivo virulence testing.
CAPSULES
To get established in the oral cavity, microorganisms must ﬁrst
adhere to teeth or to mucosal surfaces (Yoshimura et al., 2009).
Adherence is essential for providing resistance to the ﬂow of
saliva. Adherence is usually mediated by adhesins on the surface
of bacteria and by receptors on the oral surface. Microbial
adhesins are found as cell wall components or are associated
with cell structures, such as capsules or ﬁmbriae (Marcotte and
Lavoie, 1998). The chemical composition of the capsule diﬀers
between strains, mainly in their sugar composition. For instance,
P. gingivalisATCC 53977 does not contain galactose but is rich in
amino sugars. P. gingivalis is found to display at least six serotypes
of capsular antigens, which comprises K1–K6 (Laine et al., 1997).
One of the earliest studies reported that highly encapsulated
P. gingivalis strains exhibit decreased autoagglutination, lower
densities and are more hydrophilic than the non-encapsulated
strains (Van Steenbergen et al., 1987). According to Singh et al.
(2011), increased encapsulation is also correlated with increased
resistance to phagocytosis, serum resistance, and decreased
induction of polymorphonuclear leukocyte chemiluminescence.
In addition, the capsule is also found to be involved in the
perturbation of gingival epithelial cells. Studies by Dierickx et al.
(2003) revealed that the presence and type of capsule had a
signiﬁcant inﬂuence on the initial adhesion of P. gingivalis to
human periodontal pocket epithelial cells. However, it should be
noted that the capsule may possibly interact with surface protein
to facilitate attachment to the host cells. On the other hand, the
level and mechanism of co-aggregation between P. gingivalis and
another periodotopathogen, Fusobacterium nucleatum has been
shown to be capsular dependent (Rosen and Sela, 2006) as well.
Another study by Katz et al. (1996) revealed that the virulent
P. gingivalis W83 and W50 which have thicker capsules cause a
decrease in the production of leukocytes than those strains which
are less virulent such as strain 376. This clearly indicates that the
observed diﬀerence in virulence strains is likely due to diﬀerence
in capsular structure and adhesion capacity.
Studies using mouse infection models have revealed that
by shielding microbial surface components, encapsulated
P. gingivalis strains are more virulent than non-encapsulated
strains. Non-encapsulated strains mostly cause non-invasive,
localized abscesses whereas encapsulated strains cause invasive,
spreading phlegmonous infections after subcutaneous
inoculation of experimental animals. The non-encapsulated
strains are also subjected to increased phagocytosis or are killed
quickly by macrophages and dentritic cells (Laine et al., 1997).
On the contrary, in terms of invasion eﬃciency, the capsule of
P. gingivalismakes it less eﬃcient in invading gingival ﬁbroblast
compared to the non-capsular strains (Irshad et al., 2012). Recent
ﬁndings by Brunner et al. (2010) demonstrated that encapsulated
P. gingivalis was able to modulate the host response to bacteria
by reducing the synthesis of cytokines interleukin-1 (IL-1),
IL-6, and IL-8 by ﬁbroblasts. On top of its immunomodulating
properties, capsule was shown to promote virulence using mouse
abscess model by reducing phagocytosis and thereby increasing
bacterial survival within host cells, and ultimately a long-term
inﬂammatory response (Singh et al., 2011). However, the eﬀect
of oxidative stress on expression of capsule was not taken into
account as the experiments were performed under anaerobic
conditions. Further validations are needed to show a more
precise contribution of capsule in pathogenicity. In additional
to bacterial survival, capsule may also contribute to increased
survival by reducing the bactericidal eﬀect of small antimicrobial
peptide known as defensins (Igboin et al., 2011). This study used
Drosophila melanogaster killing model to characterize the host
response to P. gingivalis infection. Hence, the ﬁndings might
not be very signiﬁcant as Drosophila is not a natural host for
P. gingivalis and host–pathogen interactions could not be studied
using this organism.
In the past decade, the regulatory mechanisms in synthesis
of capsular surface has been the object of great attention. It is
believed that the mechanisms are quite complicated, involving
posttranscriptional regulation and expression of biosynthetic
machinery from multiple loci. To date, only two diﬀerent
regulatory mechanisms have been identiﬁed in P. gingivalis. One
is a tyrosine phosphatase (Ltp1) encoded by PG1641, which
controls expression of a number of genes encoding proteins
involved in the synthesis of surface polysaccharides. In the
ltp1 deletion mutant, the expression of K-antigen capsule was
downregulated (Maeda et al., 2008). The second regulatory
mechanism that has been identiﬁed is the DNABII protein
HU β-subunit (PG0121) which likewise, caused a decrease in
expression of K-antigen synthesis locus in PG0121 mutant
(Priyadarshini et al., 2013; Tjokro et al., 2014). The latest study
by Bainbridge et al. (2015) demonstrated that an antisense RNA
molecule which is encoded within the 77 bp inverted repeat
element near the 5′ end of the K-antigen capsule synthesis genes
aﬀect the expression of capsular surface in virulent P. gingivalis
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strain W83. Deletion of this element diminished the capsule
synthesis and altered the structure of LPS (Bainbridge et al.,
2015). This major ﬁndings are important in elucidating the
regulatory role of secondary structure of RNA in modulating
the synthesis of K-antigen capsule. However, it is not known if
the antisense RNA is a genuine RNA or encodes for a signaling
peptide. Furthermore, it is not known if other regulatory genes
may play a role in interacting with other proteins or enzymes in
capsule production.
FIMBRIAE
Fimbriae are thin, proteinaceous surface appendages that
protrude from the outer membrane of a bacterial cell. These
3–25 μm long structures are harbored by most of the P. gingivalis
strains. Research on P. gingivalis ﬁmbriae has a long history going
back to the 1980s (Handley and Tipler, 1986). Studies showed that
P. gingivalis expresses two distinct ﬁmbriae on its cell surface: one
consists of a subunit protein (named FimA or ﬁmbrillin) encoded
by the fimA gene (termed long, or major ﬁmbriae), while the
other subunit Mfa protein is encoded by the mfa1 gene (termed
short, minor or Mfa1 ﬁmbriae). Even though the two ﬁmbriae are
antigenically distinct and diﬀer in their amino acid composition,
they are believed to contribute to the progression of periodontal
inﬂammatory reactions (Amano et al., 2010). Interestingly, a
major ﬁmbria-like structure was found in a P. gingivalis strain
in which neither FimA nor Mfa1 ﬁmbriae was detected. This
53 kDa novel ﬁmbriae is another major outer membrane protein
of P. gingivalis (Nagano et al., 2015).
Depending on the strain, the FimA protein varies in size from
40.5 to 49 kDa. Based on the amino terminal and the DNA
sequences, it is classiﬁed into six types: types I–V and Ib (Fujiwara
et al., 1993; Hajishengallis et al., 2008). Strains with type IV FimA
such as strains W50 and W83, are poorly ﬁmbriated. Strains
381, ATCC 33277, and HG565, on the hand, are abundantly
ﬁmbriated type I strains that have signiﬁcant adhesion to host
tissues. It was reported that most of the periodontal patients
harbored FimA type II strains followed by type IV (Amano et al.,
2004).
Research on the 67-kDa minor ﬁmbria is very much limited.
The clonal diversity of minor ﬁmbriae is not well-studied among
P. gingivalis strains. Similar to FimA protein, distinct minor
ﬁmbriae molecules, FimCDE, are found in diﬀerent strains.
A study by Amano et al. (2004) demonstrated that minor ﬁmbriae
stimulated the production of interleukin-1α (IL-1α), IL-1β, IL-
6, and tumor necrosis factor-α (TNF-α) by macrophages. It is
highly postulated that the minor ﬁmbria is a causative factor of
alveolar bone resorption in animal models. This study, however,
requires further validation as clonal diversity of minor ﬁmbriae is
unclear but it is likely to contribute to the progression of human
periodontitis.
Early studies in 1990s on P. gingivalis ﬁmbriae deﬁciency
strains revealed the essential roles of ﬁmbriae in the binding
as well as invasion of host cells (Lee et al., 1992; Sharma
et al., 1993). It also mediates adherence to a wide range of oral
substrates and molecules including extracellular matrix proteins,
oral epithelial and commensal bacteria such as streptococci and
Actinomyces viscosus (Amano, 2007). Amano (2010) reported
that ﬁmbriae type II is capable of adhering to cellular α5β1-
integrin which enables the bacteria to be easily engulfed by
host phagocytes and dendritic cells and causes actin cytoskeleton
rearrangement to facilitate internalization. Subsequently, this
allows the intracellular bacteria to impair the host cellular
function with their virulence factors (Zenobia and Hajishengallis,
2015; Figure 3). It was reported that the major ﬁmbriae is
involved in the initial invasion of osteoblasts by P. gingivalis,
but are not essential for the subsequent inhibition of osteoblast
diﬀerentiation and mineralization (Zhang et al., 2011).
Many reports argue the binding of FimA residues in the
ﬁmbriae to the target molecules, but it is reported that minor
components of FimCDE critically function as an adhesin
(Yoshimura et al., 2009). FimA protein was not essential for
the invasive capabilities of P. gingivalis outer membrane vesicles.
Nevertheless, higher number of protein components associated
with vesicles derived from a ﬁmbriated strain are internalized into
human gingival ﬁbroblasts in comparison to a ﬁmbriated strain
(Mantri et al., 2015). In addition, P. gingivalis ﬁmbriae act as an
important virulence factor in atherosclerosis progression. It was
reported that P. gingivalis infection reduced regulatory T cells
(Tregs) in atherosclerotic patients. Tregs may play a crucial role
in autoimmune response during this process. However, whether
P. gingivalis infection is associated with Tregs dysregulation
during atherosclerosis is still unknown and the prevalence
of diﬀerent P. gingivalis FimA genotypes during this process
remains unclear (Yang et al., 2014).
Meanwhile, there are various plant-derived compounds used
to inhibit activity of P. gingivalis. Two of these studies were
performed by Murakami et al. (2015) on anti-inﬂammatory
activity of quercetin, resveratrol, and its related compounds,
catechin, epicatechin, orcinol, and 4-allylphenol. It was
demonstrated that the natural compounds exhibited inhibitory
eﬀect on the activity of P. gingivalis ﬁmbriae. However, it should
be noted that more studies on diﬀerent strains of P. gingivalis
are needed to support the aforementioned hypotheses as strain
variability may have diﬀerent pathogenicity.
LIPOPOLYSACCHARIDE (LPS)
Lipopolysaccharide (LPS) is a relatively large molecule with at
least 10 kDa in size. It constitues an important component
of the bacterial outer membrane (Hamada et al., 1994). In
general, the bacterial LPS consists of a distal polysaccharide
(or O-antigen), a non-repeating “core” oligosaccharide and a
hydrophobic domain known as lipid A (or endotoxin) (Ogawa
and Yagi, 2010; Figure 4). Lipid A, the inner-most component, is
the biological active region of LPS that could cause deregulation
of the mammalian innate immune system by interacting with
both toll-like receptors 2 and 4 (Darveau et al., 2004). It has
heterogeneous acylation patterns which change according to
microenvironmental conditions and aﬀect the host immune
signaling, thereby facilitating bacterial survival in the host
(Al-Qutub et al., 2006).
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FIGURE 3 | P. gingivalis manipulation of dendritic cell entry using minor fimbriae Mfa1 and accessory proteins. The adhesive properties of fimbriae allows
P. gingivalis to evade host cells and escape the host immune surveillance. Adapted from Zenobia and Hajishengallis (2015).
FIGURE 4 | Schematic structure of lipopolysaccharide (LPS) of the outer membrane of P. gingivalis. Adapted from Ogawa and Yagi (2010).
In Gram-negative bacteria, LPS plays critical roles for
maintainance of the cellular and structural integrity, as well
as a controlling the entry of hydrophobic molecules and
toxic chemicals. In fact, the folding and insertion of outer
membrane protein could not take place in the absence of LPS
(Silhavy et al., 2010). Based on its biological activity, LPS is
found to be an important pathogenic factor among many
periodontopathic bacteria. A number of investigations have
reported the ability of this outer membrane component to
activate the host inﬂammatory responses and disrupt bone
remodeling process (Herath et al., 2011; Kato et al., 2014).
In clinically healthy periodontium, a normal inﬂammatory
response is a fundamental component of the host defense
system with the production of IL-1. IL-1 is believed to
play a role in the pathogenesis of periodontal disease
through inﬂammatory reactions through activation of toll-
like receptor 4 (Bartold and Narayanan, 2006; Jain and Darveau,
2010).
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One possible role of LPS in P. gingivalis is to disrupt
the innate host surveillance by interfering with distribution
of leukocytes in the vicinity of bacterial colonization. In fact,
P. gingivalis LPS is poorly recognized by innate host defense
system compared with the LPS of other Gram-negative species
(i.e., Escherichia coli) (Liu et al., 2008). Other than that, the
ability of gingival epithelial cells to secrete chemokine interleukin
8 (IL-8) was paralyzed, thereby activation of neutrophils,
eosinophils, and basophils are aﬀected (Yoshimura et al.,
1997; Darveau et al., 1998). This phenomeneon, known as
chemokine paralysis, results in resistance to oxidative burst-
killing by polymorphonuclear neutrophils. In the absence of an
eﬀective innate host immune defense, the number of periodontal
bacteria could increase remarkably. The rise of the bacterial
population at the gingival area coupled with the failure of
host defense system to remove them are consistent with the
observed etiology of periodontal disease. Besides inducing pro-
inﬂammatory cytokines synthesis, P. gingivalis LPS inhibits
osteoblastic diﬀerentiation and mineralisation in periodontal
ligament stem cells which participate in periodontal tissue
regeneration (Kato et al., 2014).
In addition, a recent mice study demonstrated that
P. gingivalis LPS circulates systemically in more than 50%
of periodontal patients and is found to have higher level
of matrix metalloproteinase. The low systemic LPS triggers
an inﬂammatory response in the left ventricle through
metalloproteinase, thereby causing cardiac dysfunction (DeLeon-
Pennell et al., 2013). Apart from that, LPS also stimulates
the production of thrombospondin-1, a multifunctional
extracellular matrix protein secreted by human monocytic
cells. Thrombospondin-1 stimulates macrophage migration and
modulates host inﬂammatory response (Gokyu et al., 2014).
The inﬂammatory responses are mediated by variety of genes.
One of them is plasminogen activator inhibitor type I (PAI-1)
mRNA-binding protein which was reported to be upregulated
in inﬂammatory gingiva when induced by P. gingivalis LPS
(Na et al., 2014). Even though PAI-1 plays critical roles in cell
migration, it requires further studies to understand the function
of plasminogen activator system in cell signaling pathway.
A growing body of evidences shows that several natural
compounds exhibit inhibitory eﬀect on LPS. It was reported that
alpha-mangostin caused a decrease in IL-6 and IL-8 expression
in human gingival ﬁbroblasts (Yiemwattana and Kaomongkolgit,
2015). More recent ﬁnding by Ci et al. (2015) demonstrated
the inhibitory eﬀect of grape seed proanthocyanidin extracts
on P. gingivalis LPS while Derradjia et al. (2015) reported the
roles of α-tocopherol in countering the damaging eﬀect of LPS
by reducing inﬂammatory cytokines, increasing β-defensins, an
antimicrobial peptide, and promoting gingival ﬁbroblast growth
and migration. Tormentic acid, on the other hand, was reported
to inhibit LPS-induced inﬂammatory response in human gingival
ﬁbroblasts (Jian et al., 2015). As tormentic acid is found to possess
anti-inﬂammatory eﬀect by inhibiting IL-6 and IL-8 production,
it can be a possible therapeutic agent for periodontal disease.
In a recent study by Díaz et al. (2015), it was found
that diﬀerences in LPS proﬁle of P. gingivalis clinical isolates
aﬀect colony morphology and polymyxin B resistance. Unlike
the healthy subjects, isolates from periodontal subjects were
resistance to polymyxin B and demonstrated low aggregation
ability. This resistance highly correlates with variation in LPS
proﬁles as LPS from healthy subjects lacks of high molecular
weight O-antigen moieties and anionic polysaccharide (Díaz
et al., 2015) whereas P. gingivalis isolates from periodontal
subjects produce modiﬁed lipid-A molecules. However, the
role of other LPS components are poorly understood and
the participation of other virulence factors in response to
antimicrobial compounds were not taken into consideration.
Another important point worth noting is the expression of
LPS in various P. gingivalis strains, and their roles during various
stages of infection still remains controversial. One of the main
reasons presumably could be the use of diﬀerent P. gingivalis
strains that are inevitably pleiotropic with respect to other
pathogenic properties. Hence, the basis for the variation of LPS
in diﬀerent strains has yet to be established.
PROTEASES
The ability of most P. gingivalis strains to secrete numerous
hydrolytic, proteolytic, and lipolytic enzymes along with toxic
metabolites, is one of the virulence characteristic that allows these
bacteria to thrive in the oral cavity. These enzymes usually come
into close proximity with the host cells. While some enzymes
are found within the periplasmic space, others are transported
from the outer membrane into outer membrane vesicles during
growth. One of the type of enzymes, proteases, appear to be
strongly implicated in periodontal disease progression. Among
these proteases are trypsin-, thiol-, caseinolytic proteinases, and
peptidases (Travis et al., 1997; Curtis et al., 2001).
There are generally two distinct families of proteases produced
by P. gingivalis. One of them is the cysteine proteinase family
or also known as “trypsin-like” enzyme and the other one is
serine proteinase (Bostanci and Belibasakis, 2012). The “trypsin-
like” enzymes cleave polypeptides at the C-terminal after arginine
or lysine residue. These proteinases are commonly known as
gingipains, namely gingipain R and K, that cleave after arginine
and lysine, respectively. They collectively account for 85% of
the extracellular proteolytic activity of P. gingivalis at the site
of infection (de Diego et al., 2014). There are two types
of gingipain R, namely RgpA and RgpB, while there is one
type of gingipain K, Kgp. Gingipain R degrades extracellular
matrix components, including the integrin–ﬁbronectin-binding,
cytokine, immunoglobulin and complement factors (Curtis et al.,
2001). It is also vital for the processing and maturation of the
major ﬁmbriae (FimA) (Kristoﬀersen et al., 2015). Both gingipain
R and K have been isolated frommany P. gingivalis strains grown
under diﬀerent conditions.
There are strong evidences that indicate P. gingivalis proteases
involve directly in the colonization of the periodontal pocket,
leading to destruction of supporting periodontal tissue (Andrian
et al., 2004; Dubin et al., 2013). In addition, the proteases also
confer high resistance of the microorganisms to host defense
mechanisms. Extensive investigations within the past decade have
shown that P. gingivalis proteases are involved in the degradation
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of extracellular matrix proteins such as collagen, activation of the
host matrix metalloproteinases, inactivation of plasma proteinase
inhibitors, cleavage of cell surface receptors, and deregulation
of the inﬂammatory (Potempa et al., 2000; Imamura et al.,
2003). They are also important additive agents on the growth
of T. forsythia and A. actinomycetemcomitans in a mixed-species
bioﬁlm with P. gingivalis (Bao et al., 2014; Haraguchi et al.,
2014).
Gingipain was found to degrade ﬁbrinogen and host heme
proteins which contribute to inhibition of blood coagulation
and increase bleeding, thereby enhancing the availability of
hemin for bacterial growth (Sroka et al., 2001). Hence, it may
not be surprising to ﬁnd high proliferation of P. gingivalis
within periodontal pockets in which erythrocytes are abundant.
Gingipains are also considered important in its capacity
to degrade antibacterial peptides, such as neutrophil-derived
α-defensins, complement factors, such as C3 and C4, T
cell receptors, such as CD4 and CD8 (Hajishengallis et al.,
2013; Bao et al., 2014). They also reduce the expression of
innate immune receptors CD14, which result in macrophage
hyporesponsiveness to bacterial infection. However, whether
reduced CD14 expression is linked to periodontitis induced by
P. gingivalis awaits further clariﬁcation. In a recent work by
Maekawa et al. (2014), P. gingivalis and its gingipains, proactively
manipulate host molecules, for instance, by interfering cross-
talk between C5a receptor and toll-like receptor signaling to
prevent bacterial clearance. In vitro studies have demonstrated
that gingipains participate in the regulation of inﬂammatory
mediators from various host cells, including IL-1 α, IL-1β, IL-
18 (Hamedi et al., 2009), protease-activated receptor (PAR)-2
(Belibasakis et al., 2010), or soluble triggering receptor expressed
on myeloid cells (sTREM)-1 (Bostanci et al., 2013). Nevertheless,
to this extent, there is no concrete evidence to show simultaneous
eﬀect of gingipains on these inﬂammatory mediators in the
progression of periodontitis.
Rhein, an anthraquinone from rhubarb roots, exhibits
antibacterial synergistic eﬀect with other polyphenols. It causes
a downregulation of two protease genes, rgpA and kgp, which
are associated with inactivation of host defense mechanisms and
tissue destruction (Azelmat et al., 2015). On the other hand,
theaﬂavins, the main polyphenols in black tea, markedly inhibits
the proteinase activities of P. gingivalis gingipains in a dose-
dependent manner (Kong et al., 2015). A synthetic dual protease
inhibitor, termed as KYT-41, was synthesized and found to
possess potent antibacterial activity againstP. gingivalis. This dual
inhibitor of Rgp and Kgp proteases exhibit anti-inﬂammatory
activity, thereby is thought to be a promising agent for preventing
and treating gingivitis (Kataoka et al., 2014).
OUTER MEMBRANE PROTEINS
The cell envelope of Gram-negative bacteria such as
Porphyromonas sp. comprises of two cell membranes, the outer
membrane (OM) and the inner membrane (IM). Both layers of
membranes have diﬀerent composition and structure. They are
separated by the periplasm containing the peptidoglycan layer.
While the IM is a phospholipid bilayer with numerous integral
IM proteins (Bos et al., 2007), the OM is an asymmetrical bilayer
which consists of phospholipids and lipopolysaccharide in the
inner and outer leaﬂet, respectively. The bacterial cell membrane
plays a role as the selective barrier that oﬀers protection and
allows the movements of various substances through OM porin
proteins (Nikaido, 2003). The OM proteins are generally divided
into two categories, the OM lipoproteins that are anchored to
the OM by an N-terminal lipid tail, and another is OM integral
proteins which contain membrane-spanning regions (Bos and
Tommassen, 2004).
The OM is involved in most of the speciﬁc recognition
processes as it is the most exposed region of a bacterial
cell. As relatively few major proteins exist in the OM region,
these proteins are expected to be important antigens to the
host. The formation and maintenance of periodontal bioﬁlms
is postulated to be associated with the interaction among
periodontal microﬂora which is mediated by OM proteins (Bos
et al., 2007). There are evidences that T helper cells of aggressive
periodontitis patients activated with P. gingivalis OM proteins
produced higher levels of pro-inﬂammatory cytokines such as IL-
1β and IL-6 in comparison with healthy controls (Gonzales et al.,
2014).
Analysis of proteins extracted from the OM using sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
revealed the OM consists of a diverse array of proteins
ranging in size between 20 and more than 100 kDa. The
most abundant OM proteins consistently identiﬁed are porins
and OmpA-like proteins (Bos et al., 2007). However, until
recently, research on major OM proteins in P. gingivalis
remains scarce due to hydrophobicity nature of the proteins.
Several attempts have been made to characterize the OM
proteins using diﬀerent solubilization methods (Yoshimura et al.,
2009).
One of the earliest studies is by Yoshimura et al. (1989) is in
which a 75-kDa major OM protein that exists as a high molecular
weight oligomer was successfully puriﬁed. This protein was
demonstrated byWatanabe et al. (1992) to stimulate activation of
polyclonal B-cell and production of IL-1 from mouse peritoneal
macrophages.
On the other hand, Saito et al. (1997) reported that a 40-kDa
OM protein from P. gingivalis is an important aggregation factor
on the cell surface. In this study, the antibody against the protein
inhibited the aggregation activity of P. gingivalis cells toward
A. viscosus, which is one of the pioneers to colonize the tooth
surfaces. This 40-kDa OM protein is found in many strains of
P. gingivalis, residing both at the cell surface and in extracellular
vesicle. Transcutaneous immunization of mice with 40 kDa OM
protein elicited an increase in IgG antibody which inhibited the
coaggregation of P. gingivalis vesicles (Maeba et al., 2005). In
recent years, in animal model studies by Zhang et al. (2009) and
Liu et al. (2010), vaccination of mice with 40-kDa OM protein of
P. gingivalis was demonstrated to elicit a signiﬁcant reduction of
alveolar bone loss.
The 40-kDa OM protein is also a hemin-binding protein
(Shibata et al., 2003). Meanwhile, nasal immunization with
40kDa OM protein plus cholera toxin elicits protective
Frontiers in Microbiology | www.frontiersin.org 9 February 2016 | Volume 7 | Article 53
How et al. A Review of Porphyromonas gingivalis and Its Virulence Factors
immune response against P. gingivalis in both young and
aged mice besides preventing atherosclerosis (Koizumi et al.,
2008; Cai et al., 2013). Together, the results suggest that nasal
delivery of OM protein could be a potential vaccine strategy to
provide protective immunity to human and hence prevention of
periodontitis.
In addition, the OM protein proﬁles of P. gingivalis ATCC
33277 and W83 were compared, and it was found that both
strains possess most OM proteins, such as RagA, RagB, and
OmpA-like proteins in similar distribution pattern (Imai et al.,
2005). These ﬁndings, using inmmunoblotting, suggest that these
OM proteins are surface-located immunoreactive antigen but
cross-reaction with other P. gingivalis-related strains has to be
taken into consideration.
According to Chen et al. (2011), an OM protein, LptO
(PG0027) was found to be essential for the O-deacylation of
LPS of P. gingivalis and such structural formation is postulated
to be essential to provide attachment to host cells. It also plays
important role in secretion of gingipain to the cell surface. Using
blue native PAGE analysis, LptO was found in up to seven
diﬀerent complex sizes and it interacted with another protein
complex, PG0026, in secretion of C-terminal domain proteins
(Glew et al., 2014; Saiki and Konishi, 2014). Apart from that, a
novel OM protein, coined as PG534, was found to play important
roles in producing active gingipains (Saiki and Konishi, 2010).
The activities of gingipains R (RgpA and RgpB) and gingipain
K (Kgp) in P. gingivalis with defective PG534 protein were
reduced in relative to its wildtype strain.
There are also studies to attenuate the eﬀect P. gingivalis
OM proteins. For instance, studies on natural plant extracts
such as polyphenols of Myrothamnus flabellifolia was shown to
reduce P. gingivalis adhesion and invasion up to about 50% by
interacting with bacterial OM proteins. Such anti-adhesive eﬀect
is also accompanied by cytoprotective eﬀects which relates to
cytokine secretion (Löhr et al., 2011). However, it has to be noted
that this plant extract was only tested on OM proteins but not on
other virulence components of P. gingivalis.
CONCLUSION
Taken together, P. gingivalis is a major etiological agent in the
development of chronic periodontitis. This secondary colonizer
is found to express a plethora of virulence factors involved in
colonizing the subgingival plaque and modulating the immune
responses of the host cells. In order to increase survival into the
host, P. gingivalis is able to locally invade periondontal tissue,
thereby avoiding the immune surveillance while maintaining its
viability. Each virulence factor plays important roles to hamper
the cell-mediated immune response in host. Nevertheless, in
spite of the convincing data presented in this study, it should be
cautioned that in an actual in vivo situation, the bacteria express
a whole subset of virulence factors that may interact with and
stimulate host cells in a diﬀerent way than a single virulence
factor. In addition, periodontal disease is rarely the result of
single bacteria. Hence, P. gingivalis is likely to work with other
oral microbiota to thrive in a harsh inﬂammatory condition in
periodontal pocket.
To date, numerous studies have been done to elucidate the
mechanism of virulence compounds secreted by P. gingivalis and
the cellular interaction with the host. Improved understanding
of the interaction between periodontal bacteria and host cells at
the molecular and cellular level, may ultimately have relevance
to the overall well-being of the host. In recent years, the use
of natural compounds has gained more attention to attenuate
the action of P. gingivalis. Plant-derived natural products have
been widely explored as the therapeutic roles in regulating
interactions between microorganisms. One of the appealing
therapeutic feature is bioactive compounds from plants appear
to be safe and should not cause toxicity toward human cells.
However, a comprehensive toxicity studies on these compounds
are still deemed necessary.
With tremendous progress in biomedical studies, we expect
to eventually elucidate the possible unique mechanism of
P. gingivalis and its virulence determinants. Exploration of this
ﬁeld will be of help in the development of eﬀective therapies
for controlling bacterial-induced connective tissue destruction.
These therapeutics approaches may be important in controlling
chronic P. gingivalis infections by preventing growth and
colonization of P. gingivalis.
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